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Research
Cardiovascular morbidity and mortality have 
been associated with particulate matter (PM) 
air pollution in numerous epidemiologic stud-
ies (Brook 2008; Miller et al. 2007; Pope et al. 
2004). Several pathways have been proposed 
to explain these associations, including, at 
the molecular level, increased oxidative stress 
(Gurgueira et al. 2002; Kim et al. 2004; Nel 
2005) and systemic inflammation (Chuang 
et al. 2007; Dubowsky et al. 2006; O’Neill 
et al. 2007; Rückerl et al. 2006). At the 
functional level, potential pathways include 
changes in autonomic function (Devlin et al. 
2003; Gold et al. 2005; Park et al. 2005) and 
in blood pressure (BP) (Urch et al. 2005; 
Zanobetti et al. 2004). Elevated BP is a 
major risk factor for coronary heart disease 
and stroke. To date, only a few studies have 
examined the role of PM air pollution in BP 
elevation, and these have revealed both posi-
tive (Auchincloss et al. 2008; Choi et al. 2007; 
Ibald-Mulli et al. 2001; Zanobetti et al. 2004) 
and negative (Harrabi et al. 2006; Ibald-Mulli 
et al. 2004; Madsen et al. 2006) findings.
The heterogeneous composition of PM, 
which includes a complex mixture of parti-
cles and liquid droplets consisting of organic 
chemicals, acids, metals, and dust particles, 
may explain some of the variation observed in 
these studies as a result of differences in PM 
composition across geographic regions (Brook 
2008). Growing evidence suggests that traffic-
related PM pollution contributes significantly 
to PM-related cardiovascular effects (Laden 
et al. 2000; Schwartz et al. 2005; Zanobetti 
and Schwartz 2006).
Black carbon (BC) is a traffic-related par-
ticle produced as a combustion by-product 
and has been associated more strongly than 
has fine PM [aerodynamic diameter ≤ 2.5 µm 
(PM2.5)] with a number of cardiovascular end 
points (Dockery et al. 2005a, 2005b; Gold 
et al. 2005; O’Neill et al. 2005; Schwartz et al. 
2005). BC is also associated with increased 
risk of emergency myocardial infarction hos-
pitalization (Zanobetti and Schwartz 2006). 
No studies conducted among healthy persons 
have previously assessed the relation between 
BC and BP outcomes.
We hypothesized that BC would elevate 
BP in our cohort and that this PM compo-
nent may in part explain the mixed results 
observed in the association between BP and 
PM2.5. Because PM air pollution may elevate 
BP by increasing oxidative stress (Brook 2008; 
Sørensen et al. 2003), we also hypothesized 
that the effects of BC on BP would be stron-
ger among participants with impaired anti-
oxidative defense. Therefore, we examined 
the associations of BC and PM2.5 with BP in 
a repeated-measures analysis and investigated 
the possibility of effect modification of the 
association between BC and BP by gene vari-
ants related to oxidative stress defense.
Materials and Methods
Study population. Our study participants were 
from the Veterans Administration Normative 
Aging Study. This is an ongoing longitudinal 
study of aging established in 1963, details of 
which have been published previously (Bell 
et al. 1972). Briefly, the Normative Aging 
Study is a closed cohort of 2,280 male volun-
teers from the Greater Boston, Massachusetts, 
area who were 21–80 years of age at entry and 
who enrolled after an initial health screen-
ing determined that they were free of known 
chronic medical conditions. Participants were 
reevaluated every 3–5 years using detailed 
on-site physical examinations and question-
naires. BP was measured in all participants 
still presenting for examination between April 
1999 and December 2007 (791 participants, 
1,568 clinical examinations). Some of these 
participants presented only once during this 
time period, and our analysis was restricted to 
461 participants (1,067 clinical examinations) 
with complete information regarding ambient 
BC concentrations and all covariates for at least 
two study visits, and a largely overlapping group 
of 457 participants (949 clinical examinations) 
with complete information regarding ambient 
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Ba c k g r o u n d: Particulate matter (PM) air pollution has been associated with cardiovascular 
  morbidity and mortality, and elevated blood pressure (BP) is a known risk factor for cardiovascu-
lar disease. A small number of studies have investigated the relationship between PM and BP and 
found mixed results. Evidence suggests that traffic-related air pollution contributes significantly to 
PM-related cardiovascular effects. 
oBjectives: We hypothesized that black carbon (BC), a traffic-related combustion by-product, 
would be more strongly associated with BP than would fine PM [aerodynamic diameter ≤ 2.5 µm 
(PM2.5)], a heterogeneous PM mixture, and that these effects would be larger among participants 
with genetic variants associated with impaired antioxidative defense. 
Me t h o d s : We performed a repeated-measures analysis in elderly men to analyze associations 
between PM2.5 and BC exposure and BP using mixed-effects models with random intercepts, 
adjusting for potential confounders. We also examined statistical interaction between BC and 
genetic variants related to oxidative stress defense: GSTM1, GSTP1, GSTT1, NQO1, catalase, and 
HMOX-1. 
re s u l t s: A 1-SD increase in BC concentration was associated with a 1.5-mmHg increase in systolic 
BP [95% confidence interval (CI), 0.1–2.8] and a 0.9-mmHg increase in diastolic BP (95% CI, 
0.2–1.6). We observed no evidence of statistical interaction between BC and any of the genetic vari-
ants examined and found no association between PM2.5 and BP. 
co n c l u s i o n s : We observed positive associations between BP and BC, but not between BP and 
PM2.5, and found no evidence of effect modification of the association between BC and BP by gene 
variants related to antioxidative defense.
key w o r d s : black carbon, blood pressure, epidemiology, gene–environment interactions, human, 
oxidative stress, particulate matter. Environ Health Perspect 117:1767–1772 (2009).  doi:10.1289/
ehp.0900591 available via http://dx.doi.org/ [Online 31 July 2009]Mordukhovich et al.
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PM2.5 concentrations and all covariates for at 
least two study visits. This study was reviewed 
and approved by the institutional review boards 
of participating institutions. All participants 
provided written informed consent.
Physical parameters and medical his-
tory. Study center visits were conducted 
in the morning after an overnight fast and 
abstention from smoking. Physical examina-
tions included measurement of height and 
weight, and body mass index was calculated as 
[weight (kilograms)/height (meters) squared]. 
Participants were classified as having diabe-
tes based on a physician’s diagnosis of type 2 
diabetes and/or use of diabetes medications. 
Questionnaires collected details on smoking 
habits and medication use, with responses 
confirmed by an on-site physician. Alcohol 
intake was determined using a semiquanti-
tative food frequency questionnaire. Serum 
fasting glucose concentrations were measured 
using the hexokinase method, with measure-
ments performed in duplicate on an auto-
analyzer (Leon et al. 1977).
BP measurements. At each clinical visit, a 
physician measured BP using a standard mer-
cury sphygmomanometer with a 14-cm cuff. 
Systolic blood pressure (SBP) and fifth-phase 
diastolic blood pressure (DBP) were measured 
in each arm to the nearest 2 mmHg while the 
participant was seated. The means of the right 
and left arm measurements were used as each 
participant’s systolic and diastolic BP. Although 
there was no specific rest period before meas-
urement of BP, SBP and DBP were measured 
immediately after a complete patient history 
was taken with the subject seated.
Genotyping. GSTM1. Genotyping for the 
glutathione S-transferase mu-1 (GSTM1) dele-
tion polymorphism (UniGene Hs.301961; 
UniGene 2009a) was done at the Harvard 
School of Public Health. The assay consists of 
polymerase chain reaction (PCR) amplifica-
tion of exons 4 and 5 of the GSTM1 allele. 
Because this polymorphism is a gene dele-
tion, the PCR product indicates the presence 
of one or more copies of the gene. In each 
case, concomitant amplification of the cyto-
chrome P450 1A1 gene (CYP1A1) (UniGene 
Hs.72912; UniGene 2009b) was done as a 
positive control. The PCR amplification of 
CYP1A1 results in a 312 base-pair product that 
is easily visualized in the presence or absence 
of the GSTM1 273 base-pair PCR product. 
The DNA template was prepared by mixing 
whole blood (0.5–1.0 µL) with reaction buffer 
and primers, followed by incubation. To this, 
2.5 U Amplitaq was added; PCR was then per-
formed, yielding the 273 base-pair product.
GSTP1. We genotyped two single nucle-
otide polymorphisms (SNPs) on the gluta-
thione S-transferase pi-1 gene (GSTP1) 
(UniGene Hs.523836; UniGene 2009c): 
Ile105Val (A313G, rs1695), caused by an 
A-to-G substitution that changes codon 105 
from ATC (Ile) to GTC (Val); and Ala114Val 
(C2293T, rs1799811), a C-to-T substitution 
that changes codon 114 from GCG (Ala) to 
GTG (Val) (Ali-Osman et al. 1997). Both 
SNPs were genotyped using unlabeled mini-
sequencing reactions and mass spectrometry 
via a Sequenom Mass Array MALDI-TOF 
(matrix-assisted laser desorption ionization 
time-of-flight) mass spectrometer (Sequenom, 
San Diego, CA) (Sun et al. 2000).
HMOX-1 (GT)n repeat polymorphism. 
The heme oxygenase-1 (HMOX-1; UniGene 
Hs.517581; UniGene 2009d) short-tandem-
repeat assay was designed as described by 
Yamada et al. (2000). Resulting PCR products 
were analyzed with a laser-based automated 
DNA sequencer, and the sizes were compared 
with the human genome sequence (http://
genome.ucsc.edu/) to determine the number 
of repeats.
NQO1 and catalase. SNPs within 
the cata  lase gene (UniGene Hs.502302; 
UniGene 2009e) [C/T (rs480575); C1167T 
(rs769217); C(–262)T (rs1001179); A/G 
(rs2284367); and A/G (rs2300181)] and 
NAD(P)H   quinine oxidoreductase 1 gene 
(NQO1; UniGene Hs.406515; UniGene 
2009f) [C609T (rs1800566)] were genotyped 
using the Sequenom MassArray MALDI-TOF 
mass spectrometer (Sequenom) with semi-
automated primer design (SpectroDESIGNER, 
Sequenom).
GSTT1. Analyses were performed at the 
Harvard School of Public Health using the 
TaqMan 5´ nuclease real-time quantitative 
PCR assay. Subjects were genotyped for glu-
tathione S-transferase theta-1 gene (GSTT1) 
deletions (UniGene Hs.268573; UniGene 
2009g). For this analysis, the following prim-
ers and probe were used: GSTT1 exon 1 for-
ward primer (5´-caggtcagcacttaagcgatgc-3´), 
GSTT1 reverse primer (5´-cagcagtcctaggg
tcccagtta-3´), and GSTT1 probe (5´-Fam-
ccttcaaggctggcaccttcttgagg-Tamra-3´).
BC, PM2.5, and meteorologic measure-
ments. Continuous BC and PM2.5 concentra-
tions were measured at a Harvard School of 
Public Health monitoring site located at the 
Countway Library (Boston, MA), 1 km from 
the clinical examination site, and were aver-
aged by hour before BP measurement. BC 
was measured using an aethalometer (Magee 
Scientific, Berkeley, CA), and PM2.5 was 
measured using a tapered element oscillat-
ing microbalance (model 1400A; Rupprecht 
& Pataschnick Co., East Greenbush, NY), 
operated at 50°C with two 4-L/min PM2.5 
impactors before the inlet. We obtained tem-
perature and relative humidity measures from 
the Boston airport weather station.
Statistical methods. We analyzed asso-
ciations between both BC and PM2.5 expo-
sures and BP in a repeated-measures study 
using linear mixed-effects models with ran-
dom intercepts and a block-diagonal (com-
pound symmetry) covariance structure. In 
this approach, individual-level covariates are 
allowed to explain differences across subjects. 
In addition, a separate random intercept is 
fitted for each subject, so essentially all dif-
ferences across subjects are controlled and the 
estimates of association reported are effectively 
from within-subject differences.
Previous studies have suggested that lon-
ger averaging times are more relevant to the 
association between PM and BP (Zanobetti 
et al. 2004), so we used 7-day moving aver-
ages of ambient BC and PM2.5 concentrations 
matched on the time of BP measurement for 
each participant. As a sensitivity analysis, we 
also evaluated the relation between PM and 
BP using averaging times ranging from 1 hr to 
7 days before BP measurement. We evaluated 
SBP and DBP as dependent variables.
The following covariates were chosen 
a priori and included in the regression mod-
els regardless of statistical significance: age 
(years), cigarette smoking (never, current, or 
former), pack-years of smoking, body mass 
index (kilograms per square meter), alcohol 
intake (< 2 drinks per day vs. ≥ 2 drinks per 
day), fasting glucose (millimoles), current sta-
tin use (yes/no), diabetes status (yes/no), race/
ethnicity, years of education, hour of clinical 
visit, year of clinical visit, weekday of clini-
cal visit, and season of clinical visit (spring: 
March, April, May; summer: June, July, 
August; fall: September, October, November; 
winter: December, January, February). We 
also included temperature (degrees Celsius; 
7-day moving average) and relative humidity 
(percent; 7-day moving average) in our models 
a priori, along with their quadratic terms. Both 
temperature and relative humidity variables 
were centered on their means.
We identified current antihypertensive 
medication use (yes/no) as a potential con-
founder a priori. Because these medications 
may be protective for the association between 
PM air pollution and BP, we also tested for 
interactions with the pollutants before enter-
ing the medication variable into models to 
control for confounding. In addition, we 
conducted a sensitivity analysis to examine 
the effect of including antihypertensive medi-
cation use in our regression models because 
of concern about adjusting for a potential 
downstream consequence of the BP outcome. 
Exclusion of this variable did not appreciably 
alter results (data not shown). After weighing 
the evidence, we decided to include a term for 
current antihypertensive medication use in all 
regressions.
We also examined effect modification of 
the association between BC and BP by gene 
variants related to oxidative stress defense, 
because of prior research findings regarding Black carbon, oxidative stress, and blood pressure
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mechanisms mediating the hypertensive effect 
of PM air pollution (Brook 2008; Sørensen 
et al. 2003). We examined polymorphisms 
in the following antioxidative-defense–related 
genes: GSTM1, GSTP1, GSTT1, HMOX-1, 
NQO1, and catalase.
To assess effect modification by GSTM1 
and GSTT1 genotypes (wild type vs. null) and 
by HMOX-1 microsatellite (GT)n repeat length 
(< 25 repeats vs. ≥ 25 repeats), we modeled sep-
arate regressions stratified by genotype and also 
added interaction terms between BC concen-
tration and each genotype to respective main 
effects models. To assess effect modification by 
SNPs, we first aggregated information regard-
ing each SNP and classified the genotypes in 
two different manners: categorical (wild-type 
vs. any variant allele) and continuous (0, 1, or 
2 variant alleles). For both of these classifica-
tions, we modeled separate regressions stratified 
by genotype and also added an interaction term 
between BC and the aforementioned variables 
to respective main effects models.
We conducted a simulation study to ana-
lyze our power to detect gene–environment 
interactions. We generated repeated measures 
of exposure as multivariate normal with a cor-
relation of 0.2 across multiple measurements, 
which were separated by approximately 4 years 
on average in our cohort. We then generated 
random binomial data to represent genotype, 
varying prevalence rates and the interaction 
between exposure and genotype, and generated 
the outcome to be multivariate normal with a 
higher correlation between repeated measures 
(0.5). We took the main effect of exposure to 
be the average of the effect we found for DBP 
and SBP, and the variance of the outcome to 
be the mean of the variances of the two BP 
measures. We then performed a regression on 
the data and calculated the t-statistic for the 
interaction. Finally, we repeated this analysis 
1,000 times for relative effect modification of 
2 and 3 and took the power to be the fraction 
of time a significant interaction was found.
Results
Study population. Our study population con-
sisted entirely of males, most of whom were 
former cigarette smokers and current anti-
hypertensive medication users at their first 
study center visit (Table 1). At this initial exam-
ination, participants evaluated for the asso-
ciation between BC and BP had a mean age of 
71 years, a mean body mass index of 28 kg/m2, 
and average SBP and DBP of 132 mmHg and 
78 mmHg, respectively. Participants evaluated 
for the association between PM2.5 and BP had 
a mean age of 72 years, a mean body mass 
index of 28 kg/m2, and average SBP and DBP 
of 131 mmHg and 76 mmHg, respectively. 
In both of these groups, we averaged pollut-
ant concentrations across all study center visits 
and found that mean BC concentration was 
1.1 µg/m3 and mean PM2.5 concentration was 
12 µg/m3.
Associations of BC and PM2.5 concentra-
tions with BP. We evaluated the associations 
of SBP and DBP with both ambient BC and 
PM2.5 concentrations and express the results 
as the change associated with a 1-SD (equiva-
lent to 0.43 µg/m3 for BC and 4.98 µg/m3 for 
PM2.5) increment in exposure to each pollut-
ant (Table 2). We found that a 1-SD increase 
in BC concentration was associated with a 
1.46-mmHg increase in SBP [95% confidence 
Table 1. Descriptive statistics at baseline for participants with information on BC (n = 461) and PM2.5 con-
centrations (n = 457).
Study variable Subjects with BC Subjects with PM2.5
BC (µg/m3)a,b 1.10 ± 0.43 1.06 ± 0.44
PM2.5 (µg/m3)a,b 12.15 ± 4.98 12.06 ± 4.93
Age (years) 71.16 ± 6.46 72.18 ± 6.74
Body mass index (kg/m2) 28.07 ± 3.89 27.95 ± 3.92
Smoking status [no. (%)]
Never-smoker 114 (29.53) 116 (28.86)
Former smoker 259 (67.10) 269 (66.92)
Current smoker 13 (3.37) 17 (4.23)
Lifetime smoking (pack-years) 27.38 ± 23.05 28.25 ± 23.77
Alcohol intake (≥ 2 drinks/day) [no. (%)] 76 (19.69) 80 (19.90)
Temperature (ºC)a 12.18 ± 7.49 11.76 ± 7.85
Relative humidity (%)a 68.70 ± 8.74 69.61 ± 8.60
Antihypertensive medication [no. (%)]
Any 215 (55.70) 243 (60.45)
Calcium channel blockers 45 (11.66) 50 (12.44)
Angiotensin-converting enzyme inhibitors 67 (17.36) 80 (19.90)
Angiotensin receptor agonists 19 (4.92) 22 (5.47)
Beta blockers 114 (29.53) 127 (31.59)
Alpha blockers 46 (11.92) 59 (14.68)
Diuretics  69 (17.88) 81 (20.15)
Statin use [no. (%)] 118 (30.57) 131 (32.59)
Season of clinical visit [no. (%)]
Spring 90 (23.32) 101 (25.12)
Summer 80 (20.73) 102 (25.37)
Fall 145 (37.56) 119 (29.60)
Winter 71 (18.39) 80 (19.90)
Weekday of clinical visit [no. (%)]
Monday  22 (5.70) 11 (2.74)
Tuesday 91 (23.58) 103 (25.62)
Wednesday 161 (41.71) 198 (49.25)
Thursday 112 (29.02) 90 (22.39)
Diabetes [no. (%)] 41 (10.62) 47 (11.69)
Race/ethnicity [no. (%)]
Non-Hispanic white 376 (97.41) 391 (97.26)
Non-Hispanic black 6 (1.55) 7 (1.74)
Hispanic white 3 (0.78) 3 (0.75)
Hispanic black 1 (0.26) 1 (0.25)
Years of education 14.58 ± 2.70 14.65 ± 2.71
Fasting plasma glucose (mmol) 106.97 ± 25.30 106.03 ± 23.85
BP (mmHg)
SBP 132.44 ± 16.60 131.21 ± 17.26
DBP 77.75 ± 8.96 76.46 ± 9.55
Values are mean ± SD or no. (%). 
aSeven-day moving average. bMean concentration reported across all study visits rather than just at baseline (1,067 
clinical visits for BC, 949 clinical visits for PM2.5).
Table 2. Mixed linear effects models estimating the change in BP (mmHg) associated with a 1-SD increa-
sea in BC (1,067 visits) and PM2.5 (949 visits) levels.b
Change in BP (95% CI)
Air pollutant SBP DBP
BC 1.46 (0.10 to 2.82)* 0.87 (0.15 to 1.59)*
PM2.5 0.45 (–0.71 to 1.61) 0.01 (–0.60 to 0.61)
aCorresponding to a 0.43-µg/m3 increase in 7-day average BC concentrations and a 4.98-µg/m3 increase in 7-day aver-
age PM2.5 concentrations. bAll regression models are adjusted for age, cigarette smoking, pack-years of smoking, sea-
son of clinical visit, weekday of clinical visit, body mass index, diabetes status, statin use, fasting glucose level, 7-day 
moving average of temperature (linear and quadratic), 7-day moving average of relative humidity (linear and quadratic), 
hour of clinical visit, year of clinical visit, years of education, race/ethnicity, antihypertensive medication use, and daily 
alcohol intake. *p < 0.05.Mordukhovich et al.
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interval (CI), 0.10–2.82; p = 0.0356] and 
a 0.87-mmHg increase in DBP (95% CI, 
0.15–1.59; p = 0.0180). In contrast, we did 
not find an association between PM2.5 and 
either SBP or DBP (Table 2). For BC, asso-
ciations were strongest using a 7-day moving 
average, and associations between PM2.5 and 
BP remained close to the null for all averaging 
times examined (data not shown).
Effect modification by SNPs in oxida-
tive stress genes. We observed no evidence of 
statistically significant interaction between 
BC concentration and any of the gene vari-
ants assessed (Tables 3 and 4) using either 
  categorical or continuous classifications 
of SNPs.
Effect modification by antihypertensive medi-
cation use. We found no evidence of statistical 
interaction between PM2.5 and antihyperten-
sive medication use (data not shown). Similarly, 
stratified estimates for the effects of BC on BP 
differed very little by use of antihypertensive 
medications and did not show a consistent dif-
ference for SBP and DBP (data not shown).
Power to detect gene–environment inter-
actions. Our simulation study showed that, 
for a relative effect modification of 2, we had 
47% power for a gene prevalence of 20% 
rising to 67% power for a gene prevalence 
of 50%. However, for a relative effect modi-
fication of 3, we had 81% power even with a 
gene prevalence of 20%.
Discussion
We found that BC concentration averaged 
over the 7 days preceding each study center 
visit was positively associated with SBP and 
DBP in a cohort of elderly men. We did not 
observe an association between a 7-day mov-
ing average of PM2.5 and either SBP or DBP 
and did not find evidence of effect modifica-
tion of the association between BC and BP by 
genotypes related to oxidative stress defense. 
Ours is one of few studies to assess the rela-
tion between PM air pollution and BP among 
participants otherwise healthy at baseline. BC 
is a traffic-related particle, and our findings of 
a relation between BC and BP, if confirmed, 
may have important implications because of 
widespread exposure to traffic emissions across 
the U.S. population.
A panel study of 16 elderly subjects with 
respiratory disease did not reveal an associa-
tion between BC and BP (Jansen et al. 2005). 
Furthermore, although a repeated-measures 
analysis of 62 cardiac rehabilitation patients 
showed that 120-hr averages of ambient 
BC were positively associated with resting 
DBP in single-pollutant models, this asso-
ciation was found to be confounded by PM2.5 
(Zanobetti et al. 2004). A randomized trial of 
an improved cook stove among Guatemalan 
women showed that the use of chimney 
woodstoves, which resulted in lower personal 
PM exposures, was associated with a reduc-
tion in SBP and DBP relative to a traditional 
open-wood-fire control group (McCracken 
et al. 2007). Wood smoke is an important 
source of BC exposure.
The literature regarding the relation between 
PM and BP is inconsistent. Epidemiologic 
studies have shown positive (Auchincloss et al. 
2008; Choi et al. 2007; Dvonch et al. 2009; 
Ibald-Mulli et al. 2001; Zanobetti et al. 2004), 
null (Jansen et al. 2005; Madsen et al. 2006), 
and inverse associations (Harrabi et al. 2006; 
Ibald-Mulli et al. 2004) between PM and BP 
end points, and the results of chamber stud-
ies have been inconsistent, as well (Brook 
et al. 2002; Urch et al. 2005). Auchincloss 
et al. (2008) report associations between PM2.5 
and BP only in areas with a high impact from 
traffic. Similarly, Dvonch et al. (2009) found 
much stronger associations between PM2.5 
and BP in an area with high traffic density 
relative to other sections of the same city. 
Discrepant findings between investigations 
may be attributable to differences in study 
design and population susceptibility, as well 
as varying composition of PM across study 
sites. In particular, investigations include cross-
sectional studies that are more susceptible to 
confounding by factors varying across subjects, 
panel studies with small numbers of subjects 
but many repeated measures, and those like 
the present study, with a smaller number of 
repeated measures in a larger cohort.
Table 3. Modification of the association between a 1-SD increase in BC and BP (mmHg) by SNPs related 
to antioxidative defense.a
Change in BP (95% CI)
Genetic variant SBP DBP
Catalase C/T (rs480575)
CC (n = 480) 1.27 (–0.77 to 3.30) 0.62 (–0.49 to 1.74)
CT (n = 358) 1.36 (–1.16 to 3.89) 0.57 (–0.74 to 1.88)
TT (n = 103)  –0.53 (–5.27 to 4.21) 0.59 (–2.12 to 3.29)
p-Value for interaction 0.50  0.77
Catalase C1167T (rs769217) 
CC (n = 539) 1.40 (–0.52 to 3.32) 0.66 (–0.37 to 1.70)
CT (n = 336) 1.49 (–1.05 to 4.04) 0.59 (–0.77 to 1.94)
TT (n = 62) 2.51 (–3.90 to 8.92) 0.42 (–3.19 to 4.03)
p-Value for interaction 0.37 0.95
Catalase C(–262)T (rs1001179) 
CC (n = 594) 1.17 (–0.66 to 3.01) 0.40 (–0.61 to 1.41)
CT (n = 289) 0.99 (–1.75 to 3.73) 0.97 (–0.39 to 2.33)
TT (n = 50) 1.44 (–8.10 to 10.98) 3.56 (–0.63 to 7.75)
p-Value for interaction  0.65  0.42
Catalase A/G (rs2284367)
AA (n = 534) 1.35 (–0.58 to 3.28) 0.68 (–0.36 to 1.72)
AG (n = 305) 1.76 (–0.93 to 4.46) 0.67 (–0.72 to 2.06)
GG (n = 73) 7.20 (1.46 to 12.93) 2.24 (–1.34 to 5.83)
p-Value for interaction 0.61  0.80
Catalase A/G (rs2300181)
AA (n = 498) 2.05 (0.06 to 4.04) 0.64 (–0.40 to 1.68)
AG (n = 358) 0.56 (–1.91 to 3.02) 0.38 (–0.87 to 1.64)
GG (n = 74) 2.33 (–3.77 to 8.42) 3.59 (–0.15 to 7.32)
p-Value for interaction 0.28  0.31
GSTP1 C2293T (rs1799811) 
AA (n = 769) 1.29 (–0.31 to 2.90) 0.47 (–0.38 to 1.32)
AG (n = 116) –0.24 (–5.15 to 4.68) 1.08 (–1.37 to 3.52)
GG (n = 5)b — —
p-Value for interaction 0.33 0.66
GSTP1 A313G (rs1695) 
AA (n = 440) 3.20 (0.91 to 5.49) 0.83 (–0.36 to 2.01)
AG (n = 363) –0.53 (–2.77 to 1.70) 0.10 (–1.14 to 1.33)
GG (n = 86) –0.29 (–6.44 to 5.85) 2.48 (–0.26 to 5.21)
p-Value for interaction 0.38 0.46
NQO1 C609T (rs1800566) 
CC (n = 680) 1.85 (0.08 to 3.62) 1.10 (0.15 to 2.04)
CT (n = 298) 1.43 (–1.13 to 4.00) 0.50 (–0.86 to 1.86)
TT (n = 35) –6.28 (–21.07 to 8.52) –1.23 (–8.46 to 6.01)
p-Value for interaction 0.28 0.16
aAll counts reported correspond to number of study center visits. Interaction test results represent interactions between 
BC and variant allele number only. All regression models are adjusted for age, cigarette smoking, pack-years of smok-
ing, season of clinical visit, weekday of clinical visit, body mass index, diabetes status, statin use, fasting glucose level, 
7-day moving average of temperature (linear and quadratic), 7-day moving average of relative humidity (linear and qua-
dratic), hour of clinical visit, year of clinical visit, years of education, race/ethnicity, antihypertensive medication use, 
and daily alcohol intake. bInsufficient sample size to obtain sample estimates.Black carbon, oxidative stress, and blood pressure
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Research regarding mechanisms medi-
ating BC’s hypertensive effects is quite lim-
ited. Plasma markers of systemic oxidative 
stress and inflammation have been associated 
with BC exposure in epidemiologic studies 
(Delfino et al. 2008; Sørensen et al. 2003). 
However, much of our discussion regarding 
potential mechanisms of BC cardiotoxicity is 
informed by broader PM research. Our results 
suggest that BC may be primarily responsible 
for the association of PM with BP.
In addition to examining effects of BC 
on BP, we also hypothesized that these effects 
would be stronger among participants with 
genetic variants associated with impaired oxi-
dative stress defense and therefore evaluated 
statistical interactions between BC exposure 
and relevant gene variants. We did not find 
statistically significant evidence of effect mod-
ification by antioxidative defense genes in this 
analysis. Although our findings may suggest 
that the effect of BC on BP is not mediated 
by the oxidative stress–related mechanisms 
associated with the examined genetic vari-
ants, this analysis may not have had sufficient 
power to assess lower levels of effect modifica-
tion. Specifically, based on a simulation study, 
our investigation had limited power to detect 
a relative effect modification of 2 but reason-
able power to detect a relative effect modifi-
cation of 3. For some genotypes, including 
GSTM1, GSTT1, and GSTP1, we found a 
relative effect modification of approximately 2 
in this analysis, so our lack of significance may 
be a result of power limitations.
Study limitations. One potential limita-
tion of our study is the use of stationary meas-
ures of air pollution to represent personal 
exposures. Prior research indicates that this 
exposure misclassification is likely to lead to 
an underestimation of the health effects of air 
pollution (Zeger et al. 2000). Several studies, 
including one conducted in the Greater Boston 
area, have found that longitudinal measures 
of ambient PM concentrations are representa-
tive of longitudinal variation in personal expo-
sures (Nethery et al. 2008; Rojas-Bracho et al. 
2000). Hence, although the use of ambient 
measurements clearly introduces measurement 
error into the study, it is not to an unaccept-
able level. Moreover, Zeger et al. (2000) have 
shown that most of the measurement error 
in such cases is Berkson error, which reduces 
power to find a significant effect but does not 
bias the estimated effect size. Another potential 
limitation of our study design was that BP was 
read only once at each clinical visit, because 
BP is dynamic and responsive to many stim-
uli. Furthermore, nonambient PM exposures 
within or on the way to the clinic were not 
measured in our study.
Our study population is homogeneous, 
consisting entirely of elderly men, 97% of 
whom are white. However, our findings are 
consistent with studies of PM air pollution 
conducted in more heterogeneous popula-
tions. The Normative Aging Study cohort was 
not originally recruited to study the effects of 
air pollution. A number of our participants 
had only two clinical visits. Although subjects 
with two measurements obviously contribute 
less power to the analysis than subjects with 
three or more measurements, we believe that 
the study is well powered, with 1,067 total 
observations for BC and 949 total observa-
tions for PM2.5 as well as substantial fluctua-
tion in weekly measurements of air pollution 
over time. Last, we did not correct for mul-
tiple comparisons in this analysis. However, 
we have taken a targeted pathway approach 
and examined genetic variants known to be 
associated with oxidative stress.
Conclusions
More research is needed to address the rela-
tion between BC exposure and BP among 
diverse study populations and to clarify 
the mechanisms underlying the association 
between BC and BP. Potential effect modi-
fication of the association between BC and 
BP by genes affecting endothelial function, 
inflammation, and oxidative stress pathways 
should be explored in future studies.
Our analysis indicates a positive associa-
tion between ambient BC concentration and 
BP. We found no evidence of effect modifica-
tion of this relation by gene variants related to 
oxidative stress defense, possibly due to insuf-
ficient power, and did not observe an asso-
ciation between PM2.5 and BP. These results 
provide new information to guide future 
research regarding BC and PM exposures and 
cardiovascular outcomes.
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